Existing drug may help improve responses to cellular therapies in advanced leukemias
Too many "exhausted" T cells left in the wake of aggressive chemotherapy regimens for patients with advanced chronic lymphocytic leukemia (CLL) make it more challenging for chimeric antigen receptor (CAR) T cell therapy to ...
Aug 16, 2021
0
34